The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo

The clinical use of cisplatin was severely limited by its associated nephrotoxicity. In this study, we investigated whether the pseudoginsenoside F11 had protective effects against cisplatin-induced nephrotoxicity. To clarify it, one in vivo model of cisplatin-induced acute renal failure was perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongbo, Kong, Liang, Zhang, Jianqiao, Yu, Guohua, Lv, Guangyao, Zhang, Fangxi, Chen, Xiaoguang, Tian, Jingwei, Fu, Fenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023132/
https://www.ncbi.nlm.nih.gov/pubmed/24832194
http://dx.doi.org/10.1038/srep04986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023132/
https://www.ncbi.nlm.nih.gov/pubmed/24832194
http://dx.doi.org/10.1038/srep04986

Ejemplares similares